Showing results (161-170 of 218) with videos related to
Sort By:
Pageof 22
Plos One|December 20, 2012
Clinical significance of heparanase splice variant (t5) in renal cell carcinoma: evaluation by a novel t5-specific monoclonal antibodyUri Barash, Gil Arvatz, Roy Farfara, et al.Thrombosis and Haemostasis|September 21, 2018
Pro-Angiogenic Effects of Latent Heparanase and Thrombin Receptor-Mediated Pathways-Do They Share a Common Ground in Melanoma Cells?Sebastian G Hoß, Manuel Grundmann, Tobias Benkel, et al.Cancer Research|March 26, 2016
Heparanase 2 Attenuates Head and Neck Tumor Vascularity and GrowthMiriam Gross-Cohen, Sari Feld, Ilana Doweck, et al.Seminars in Thrombosis and Hemostasis|February 16, 2015
Latent heparanase facilitates VLA-4-mediated melanoma cell binding and emerges as a relevant target of heparin in the interference with metastatic progressionUrsula Gerber, Sebastian G Hoß, Anna Shteingauz, et al.Experimental Cell Research|November 21, 2002
Human heparanase is localized within lysosomes in a stable formOrit Goldshmidt, Liat Nadav, Helena Aingorn, et al.International Journal of Biological Sciences|May 29, 2026
Heparanase 2 (Hpa2) protects the exocrine pancreas from damages of Western diet and pancreatic cancerYasmin Kayal, Malik Farhoud, Maali Odeh, et al.Journal of Cellular Biochemistry|March 5, 2015
Mammary Branching Morphogenesis Requires Reciprocal Signaling by Heparanase and MMP-14Angélica Maciel Gomes, Ramray Bhat, Ana Luísa Correia, et al.The European Journal of Neuroscience|January 6, 2009
Engineering angiogenesis following spinal cord injury: a coculture of neural progenitor and endothelial cells in a degradable polymer implant leads to an increase in vessel density and formation of the blood-spinal cord barrierMillicent Ford Rauch, Sara Royce Hynes, James Bertram, et al.Journal of Cell Science|May 6, 2004
Processing and activation of latent heparanase occurs in lysosomesAnna Zetser, Flonia Levy-Adam, Victoria Kaplan, et al.The American Journal of Pathology|July 4, 2006
PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradationPurba Biswas, Sandra Canosa, David Schoenfeld, et al.Pageof 22